Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries.
about
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence.Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study.Cause of death in older men after the diagnosis of prostate cancer.Diffusion-weighted MRI and its role in prostate cancer.High b value (2,000 s/mm2) diffusion-weighted magnetic resonance imaging in prostate cancer at 3 Tesla: comparison with 1,000 s/mm2 for tumor conspicuity and discrimination of aggressivenessJoint spatial survival modeling for the age at diagnosis and the vital outcome of prostate cancer.Vitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men.Potential of magnetic nanoparticles for targeted drug deliveryProstate-cancer mortality in the USA and UK in 1975-2004: an ecological study.Supporting patients treated for prostate cancer: a video vignette study with an email-based educational program in general practiceValue of preoperative 3T multiparametric MRI for surgical margin status in patients with prostate cancer.Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study.Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells and extracellular matrix.Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-east London.Relationship Between Perineural Invasion in Prostate Needle Biopsy Specimens and Pathologic Staging After Radical ProstatectomyBiexponential apparent diffusion coefficients values in the prostate: comparison among normal tissue, prostate cancer, benign prostatic hyperplasia and prostatitis.ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.Simultaneous vs staged treatment of urolithiasis in patients undergoing radical prostatectomy.Utility of ADC measurement on diffusion-weighted MRI in differentiation of prostate cancer, normal prostate and prostatitis.Prostate cancer: socio-economic, geographical and private-health insurance effects on care and survival.Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy.Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging.Feasibility of Presurgical Exercise in Men With Prostate Cancer Undergoing Prostatectomy.Prostate cancer identification: quantitative analysis of T2-weighted MR images based on a back propagation artificial neural network model.Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy.Trends in prostate cancer incidence and survival in various socioeconomic classes: a population-based study
P2860
Q33685303-AFB213EE-A332-4A41-8341-C06222BC5FDBQ33938808-02DD0DD8-E1FB-4337-9B6A-095341DF6237Q34207357-4843336A-1F97-440B-BFB4-C68A51EAA571Q34742733-B6BD93CC-C109-4E26-A5BF-540AC531B04FQ35164071-FE346FE4-6C8C-4CC3-A86C-831DC37364B9Q36158044-D73526A1-ED05-4E65-84BD-F0BAA2A74DF7Q36551167-CD6154D4-361E-4163-95FD-7C13F662A50DQ37194054-10416E37-A876-4E57-B0F8-434229027AE8Q37384669-A2C9AE11-6772-4B12-84C6-DD670C46F86DQ38384072-FB3FFED7-28BB-4AF6-AE60-7CAAD2FC21C1Q38731500-EB0769BC-A63A-435A-8B18-F4E9360F8AACQ38821219-DBD76D3D-3F89-4174-973F-8BFC3755817BQ40221683-6E481EDC-C1E3-46EC-864A-806B18DBBC34Q40266787-05419852-177F-4BF7-B010-2B1878F92EF5Q41017090-0BA9EC50-4F6B-486E-BC45-70E9AA8A9028Q41517377-96241B07-9B80-4E14-B456-60C71F7748A0Q41880985-0F074C60-F3F1-4552-B3E2-4E61D1F11A54Q41913507-705F83AD-F098-49E5-8DFA-130592DE18F2Q42043511-14936B5D-2E2F-4457-92F8-D86216731602Q42644517-249DD682-FD9C-4BA9-AA68-2BE4FFC6C089Q45007195-9A922CA7-A097-4E17-9C1B-00FB956AD4CBQ45396642-5B625E3F-8B1E-4AB6-810B-328D7C4CBF2AQ49245059-825CB934-1421-4185-B1C6-9FAC0DE02419Q50906787-4BE9A0C3-6B2D-4D07-B670-B8EB3196F414Q55210896-24C8DA74-7086-441C-9C89-3B6ABE4890B7Q56765034-FE28A70E-CB95-4DAF-ADA4-F33254FA0E08
P2860
Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Patterns and trends in prostat ...... Part II: individual countries.
@ast
Patterns and trends in prostat ...... Part II: individual countries.
@en
Patterns and trends in prostat ...... Part II: individual countries.
@nl
type
label
Patterns and trends in prostat ...... Part II: individual countries.
@ast
Patterns and trends in prostat ...... Part II: individual countries.
@en
Patterns and trends in prostat ...... Part II: individual countries.
@nl
prefLabel
Patterns and trends in prostat ...... Part II: individual countries.
@ast
Patterns and trends in prostat ...... Part II: individual countries.
@en
Patterns and trends in prostat ...... Part II: individual countries.
@nl
P2860
P1433
P1476
Patterns and trends in prostat ...... Part II: individual countries.
@en
P2860
P304
P356
10.1046/J.1464-410X.2002.02823.X
P577
2002-07-01T00:00:00Z